

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.93570696 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.41408035 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.41408035 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.22780496 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.92218130 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.92218130 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.92218130 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.92218130 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.92218130 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.92218130 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.82754398 |
| 12 | detection of other organism (GO:0098543) | 5.77937516 |
| 13 | response to peptidoglycan (GO:0032494) | 5.57558591 |
| 14 | detection of bacterium (GO:0016045) | 5.55156477 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.20844794 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 5.14263463 |
| 17 | leukocyte aggregation (GO:0070486) | 5.02377458 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.82847579 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.73471264 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.71452050 |
| 21 | cellular extravasation (GO:0045123) | 4.70633120 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.67723017 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.60043160 |
| 24 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.49921594 |
| 25 | respiratory burst (GO:0045730) | 4.33549402 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32829460 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 4.31910802 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.27416243 |
| 29 | neutrophil activation (GO:0042119) | 4.26280131 |
| 30 | microglial cell activation (GO:0001774) | 4.24011035 |
| 31 | detection of biotic stimulus (GO:0009595) | 4.23839823 |
| 32 | response to host immune response (GO:0052572) | 4.17043565 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17043565 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 4.12922060 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 4.08643082 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.00399368 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98485680 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.98026975 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.97417288 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.94765338 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.94241673 |
| 42 | macrophage activation (GO:0042116) | 3.90679420 |
| 43 | granulocyte activation (GO:0036230) | 3.88620739 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.84223650 |
| 45 | response to host (GO:0075136) | 3.84223650 |
| 46 | response to host defenses (GO:0052200) | 3.84223650 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.80007537 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.79248174 |
| 49 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.78844271 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.77939811 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.76643355 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.74539486 |
| 53 | regulation of mast cell activation (GO:0033003) | 3.68592750 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.65008806 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.64867888 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61398220 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 3.53789315 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.53789315 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.51824944 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.42222181 |
| 61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.40413749 |
| 62 | leukocyte degranulation (GO:0043299) | 3.39154663 |
| 63 | activated T cell proliferation (GO:0050798) | 3.36450538 |
| 64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.34323616 |
| 65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30538629 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29447600 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.24937263 |
| 68 | myeloid leukocyte mediated immunity (GO:0002444) | 3.21838148 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.21133136 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.21133136 |
| 71 | response to interleukin-15 (GO:0070672) | 3.20018660 |
| 72 | regulation of regulated secretory pathway (GO:1903305) | 3.18648135 |
| 73 | response to type I interferon (GO:0034340) | 3.18184157 |
| 74 | defense response to protozoan (GO:0042832) | 3.13255958 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13008063 |
| 76 | regulation of B cell differentiation (GO:0045577) | 3.12996710 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12111278 |
| 78 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.10637081 |
| 79 | positive thymic T cell selection (GO:0045059) | 3.10514515 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 3.08722091 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06739829 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06355558 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05483282 |
| 84 | negative thymic T cell selection (GO:0045060) | 3.03134683 |
| 85 | B cell mediated immunity (GO:0019724) | 3.02524673 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02200280 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 2.98029268 |
| 88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97076453 |
| 89 | myeloid leukocyte activation (GO:0002274) | 2.96840228 |
| 90 | positive regulation of tolerance induction (GO:0002645) | 2.96485955 |
| 91 | T cell migration (GO:0072678) | 2.95496892 |
| 92 | negative T cell selection (GO:0043383) | 2.93982340 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92631144 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 2.92293961 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91684233 |
| 96 | T cell selection (GO:0045058) | 2.90895284 |
| 97 | cell wall macromolecule catabolic process (GO:0016998) | 2.89843656 |
| 98 | negative regulation of type 2 immune response (GO:0002829) | 2.87975865 |
| 99 | neutrophil chemotaxis (GO:0030593) | 2.86405149 |
| 100 | mast cell activation (GO:0045576) | 2.82728814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37310138 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68842671 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.19208492 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68031335 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.64077380 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27953270 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.26659731 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07727932 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86885056 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80574878 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73813747 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.71822529 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70528796 |
| 14 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.69942395 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68019012 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.66034151 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52151569 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44003253 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41723103 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34241733 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.34239276 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32740015 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30094371 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.28409609 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19627641 |
| 26 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19576707 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.16137822 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14293564 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10154890 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08589597 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07834471 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99678419 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.97145480 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95129034 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.92778535 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91779564 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89545248 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82130530 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79105927 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77522214 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75277523 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.71769903 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64543574 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64453635 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63896324 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57150578 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56058754 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54707718 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52484874 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51219593 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47223281 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45829309 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45639755 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44059527 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43990158 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43019515 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38123597 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36733132 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36177281 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35723124 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34502752 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33294589 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32575531 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32222672 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30825379 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30594796 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29575668 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29337040 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28771423 |
| 70 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28679701 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27003823 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26144231 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25326358 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21997546 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21673315 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21599448 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19809957 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17933408 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17498610 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17222742 |
| 81 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17190538 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16615377 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10706613 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06325181 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06014437 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98205410 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93790263 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93326106 |
| 89 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91411757 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90980539 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90779127 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90123811 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88679033 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85479929 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84011917 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83652039 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.82205478 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82104870 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81387178 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78304055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.73447194 |
| 2 | MP0003436_decreased_susceptibility_to | 4.33808925 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.90116549 |
| 4 | MP0003303_peritoneal_inflammation | 3.84046494 |
| 5 | MP0002419_abnormal_innate_immunity | 3.31220437 |
| 6 | MP0006082_CNS_inflammation | 3.09174749 |
| 7 | MP0009785_altered_susceptibility_to | 3.06027448 |
| 8 | MP0005025_abnormal_response_to | 2.98131462 |
| 9 | MP0005671_abnormal_response_to | 2.89219429 |
| 10 | MP0001800_abnormal_humoral_immune | 2.86925630 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.82945563 |
| 12 | MP0000685_abnormal_immune_system | 2.77309416 |
| 13 | MP0005387_immune_system_phenotype | 2.74523354 |
| 14 | MP0001790_abnormal_immune_system | 2.74523354 |
| 15 | MP0002723_abnormal_immune_serum | 2.58828715 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.53854393 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.52436059 |
| 18 | MP0001819_abnormal_immune_cell | 2.49512096 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.34050286 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.22102412 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.21157079 |
| 22 | MP0003828_pulmonary_edema | 2.17249963 |
| 23 | MP0008260_abnormal_autophagy | 2.14541884 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.12042310 |
| 25 | MP0002132_abnormal_respiratory_system | 2.05681582 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.05155365 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.02966696 |
| 28 | MP0002405_respiratory_system_inflammati | 1.95111808 |
| 29 | MP0002398_abnormal_bone_marrow | 1.85981114 |
| 30 | MP0000716_abnormal_immune_system | 1.84342181 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.83327825 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.76659439 |
| 33 | MP0009278_abnormal_bone_marrow | 1.72156101 |
| 34 | MP0004947_skin_inflammation | 1.70382945 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.66463235 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.57739002 |
| 37 | MP0002722_abnormal_immune_system | 1.56795362 |
| 38 | MP0004510_myositis | 1.56368299 |
| 39 | MP0004883_abnormal_blood_vessel | 1.54793239 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.50208508 |
| 41 | MP0009764_decreased_sensitivity_to | 1.49392263 |
| 42 | MP0005310_abnormal_salivary_gland | 1.48390801 |
| 43 | MP0008469_abnormal_protein_level | 1.47411243 |
| 44 | MP0002429_abnormal_blood_cell | 1.44448870 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.43259476 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.39845113 |
| 47 | MP0003866_abnormal_defecation | 1.39011080 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.38077979 |
| 49 | MP0003690_abnormal_glial_cell | 1.35314772 |
| 50 | MP0001851_eye_inflammation | 1.35196774 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.32139093 |
| 52 | MP0003075_altered_response_to | 1.32065357 |
| 53 | MP0005451_abnormal_body_composition | 1.31617960 |
| 54 | MP0000858_altered_metastatic_potential | 1.30085489 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.29232610 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.29232610 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.28349059 |
| 58 | MP0004381_abnormal_hair_follicle | 1.23235519 |
| 59 | MP0005166_decreased_susceptibility_to | 1.16273547 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.14193550 |
| 61 | MP0005164_abnormal_response_to | 1.13675170 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.13231843 |
| 63 | MP0005410_abnormal_fertilization | 1.04685491 |
| 64 | MP0008004_abnormal_stomach_pH | 0.98807683 |
| 65 | MP0001853_heart_inflammation | 0.98687595 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.96240427 |
| 67 | MP0003448_altered_tumor_morphology | 0.92752090 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.91498076 |
| 69 | MP0000343_altered_response_to | 0.89121085 |
| 70 | MP0005390_skeleton_phenotype | 0.87426438 |
| 71 | MP0005083_abnormal_biliary_tract | 0.86556947 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 0.86184383 |
| 73 | MP0001663_abnormal_digestive_system | 0.84226249 |
| 74 | MP0009763_increased_sensitivity_to | 0.81107628 |
| 75 | MP0000604_amyloidosis | 0.80847182 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.80507121 |
| 77 | MP0001873_stomach_inflammation | 0.79455615 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.74743612 |
| 79 | MP0003878_abnormal_ear_physiology | 0.74743612 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.73122123 |
| 81 | MP0002009_preneoplasia | 0.71814572 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.70607464 |
| 83 | MP0002933_joint_inflammation | 0.69554217 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.68230339 |
| 85 | MP0002006_tumorigenesis | 0.67865586 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.66998499 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.66413561 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.65521543 |
| 89 | MP0000249_abnormal_blood_vessel | 0.65489749 |
| 90 | MP0003045_fibrosis | 0.65360602 |
| 91 | MP0008874_decreased_physiological_sensi | 0.63696570 |
| 92 | MP0003795_abnormal_bone_structure | 0.62777881 |
| 93 | MP0003091_abnormal_cell_migration | 0.62442210 |
| 94 | MP0002928_abnormal_bile_duct | 0.61905037 |
| 95 | MP0004130_abnormal_muscle_cell | 0.61762840 |
| 96 | MP0000490_abnormal_crypts_of | 0.58773129 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.57380396 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56830445 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.56437407 |
| 100 | MP0004484_altered_response_of | 0.55766948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.06033890 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.68306628 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.57254071 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.99987401 |
| 5 | Myositis (HP:0100614) | 5.85911311 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.54081474 |
| 7 | Orchitis (HP:0100796) | 5.44597088 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.31263361 |
| 9 | Optic neuritis (HP:0100653) | 5.31263361 |
| 10 | Stomatitis (HP:0010280) | 5.03027838 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78389643 |
| 12 | Recurrent skin infections (HP:0001581) | 4.33304871 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.32088197 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.28189999 |
| 15 | Obstructive lung disease (HP:0006536) | 4.22256888 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.22256888 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.13745679 |
| 18 | Meningitis (HP:0001287) | 3.93434868 |
| 19 | Gingivitis (HP:0000230) | 3.81359608 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.79832584 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.74037363 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.72912638 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.72912638 |
| 24 | Encephalitis (HP:0002383) | 3.58497931 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.50824241 |
| 26 | Urticaria (HP:0001025) | 3.45197022 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 3.42852438 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.40379813 |
| 29 | Vasculitis (HP:0002633) | 3.35868485 |
| 30 | Amyloidosis (HP:0011034) | 3.35152990 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.32601751 |
| 32 | Episodic fever (HP:0001954) | 3.25006728 |
| 33 | Increased IgE level (HP:0003212) | 3.19333086 |
| 34 | Hemoptysis (HP:0002105) | 3.13870703 |
| 35 | Cellulitis (HP:0100658) | 3.13543198 |
| 36 | Chest pain (HP:0100749) | 3.12634101 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.02304521 |
| 38 | Hypochromic anemia (HP:0001931) | 2.97695663 |
| 39 | Leukocytosis (HP:0001974) | 2.96308645 |
| 40 | Arterial thrombosis (HP:0004420) | 2.91177080 |
| 41 | Recurrent viral infections (HP:0004429) | 2.88781247 |
| 42 | Gingival bleeding (HP:0000225) | 2.88315252 |
| 43 | T lymphocytopenia (HP:0005403) | 2.86910193 |
| 44 | Peritonitis (HP:0002586) | 2.80087981 |
| 45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.77448453 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.74417366 |
| 47 | Epistaxis (HP:0000421) | 2.71944962 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.69380931 |
| 49 | Anorexia (HP:0002039) | 2.66974821 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.58267193 |
| 51 | Increased cerebral lipofuscin (HP:0011813) | 2.57277381 |
| 52 | Pustule (HP:0200039) | 2.56537863 |
| 53 | Pulmonary embolism (HP:0002204) | 2.53572050 |
| 54 | Osteomyelitis (HP:0002754) | 2.53171559 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.49821766 |
| 56 | Abnormality of T cells (HP:0002843) | 2.49144268 |
| 57 | Petechiae (HP:0000967) | 2.46215450 |
| 58 | Colitis (HP:0002583) | 2.39056585 |
| 59 | Gangrene (HP:0100758) | 2.30957655 |
| 60 | Granulocytopenia (HP:0001913) | 2.29146038 |
| 61 | Increased IgM level (HP:0003496) | 2.27079052 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.23593530 |
| 63 | Increased serum ferritin (HP:0003281) | 2.22449709 |
| 64 | Sepsis (HP:0100806) | 2.21304276 |
| 65 | Vertigo (HP:0002321) | 2.19784849 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17024444 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17024444 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17024444 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.16087551 |
| 70 | Microcytic anemia (HP:0001935) | 2.16056931 |
| 71 | Purpura (HP:0000979) | 2.14611596 |
| 72 | Loss of speech (HP:0002371) | 2.13942470 |
| 73 | Lymphopenia (HP:0001888) | 2.10222452 |
| 74 | Glomerulopathy (HP:0100820) | 2.08119911 |
| 75 | Recurrent pneumonia (HP:0006532) | 2.08089061 |
| 76 | Abnormality of the endocardium (HP:0004306) | 2.07166259 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.05925908 |
| 78 | Acne (HP:0001061) | 2.02977150 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.02561227 |
| 80 | Polyneuropathy (HP:0001271) | 2.02333939 |
| 81 | Skin ulcer (HP:0200042) | 1.98284312 |
| 82 | Slow saccadic eye movements (HP:0000514) | 1.98137363 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 1.96811284 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96125695 |
| 85 | Malnutrition (HP:0004395) | 1.95925905 |
| 86 | Abnormal platelet volume (HP:0011876) | 1.95257783 |
| 87 | Cheilitis (HP:0100825) | 1.93856533 |
| 88 | Hepatosplenomegaly (HP:0001433) | 1.92190176 |
| 89 | Amaurosis fugax (HP:0100576) | 1.91196270 |
| 90 | Acute hepatic failure (HP:0006554) | 1.90266828 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89341811 |
| 92 | Keratitis (HP:0000491) | 1.88851541 |
| 93 | Eosinophilia (HP:0001880) | 1.88846629 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 1.88776977 |
| 95 | Nasal polyposis (HP:0100582) | 1.81222681 |
| 96 | Dysostosis multiplex (HP:0000943) | 1.79389622 |
| 97 | Abnormality of the pericardium (HP:0001697) | 1.78585867 |
| 98 | Splenomegaly (HP:0001744) | 1.77603556 |
| 99 | Recurrent lower respiratory tract infections (HP:0002783) | 1.77546787 |
| 100 | IgM deficiency (HP:0002850) | 1.76557870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.21211660 |
| 2 | BLK | 3.48622004 |
| 3 | MAP4K1 | 3.30262967 |
| 4 | MAP2K3 | 3.04859208 |
| 5 | TYK2 | 2.86632801 |
| 6 | IRAK4 | 2.85322471 |
| 7 | CSK | 2.83716117 |
| 8 | PRPF4B | 2.80838410 |
| 9 | FES | 2.76237978 |
| 10 | TNK2 | 2.33635215 |
| 11 | GRK6 | 2.21105314 |
| 12 | ERN1 | 2.18812143 |
| 13 | ZAP70 | 2.14661094 |
| 14 | FGR | 2.09169398 |
| 15 | MAP3K3 | 2.05685309 |
| 16 | BTK | 1.84857493 |
| 17 | JAK3 | 1.84420545 |
| 18 | SYK | 1.77625537 |
| 19 | TXK | 1.70074090 |
| 20 | MAP3K13 | 1.68953244 |
| 21 | HCK | 1.67188989 |
| 22 | TAOK1 | 1.67055304 |
| 23 | MAP3K14 | 1.60206361 |
| 24 | EPHB1 | 1.55862742 |
| 25 | MAP3K11 | 1.54629579 |
| 26 | IKBKE | 1.48548325 |
| 27 | JAK1 | 1.36977117 |
| 28 | LYN | 1.36647207 |
| 29 | KSR2 | 1.36449799 |
| 30 | JAK2 | 1.36146449 |
| 31 | MAP3K1 | 1.29425429 |
| 32 | TBK1 | 1.26373631 |
| 33 | CSF1R | 1.21660815 |
| 34 | LCK | 1.16631763 |
| 35 | SIK3 | 1.16507181 |
| 36 | YES1 | 1.14167872 |
| 37 | KIT | 1.11638003 |
| 38 | TEC | 1.10077452 |
| 39 | TAOK3 | 1.08898542 |
| 40 | PDK1 | 1.08253245 |
| 41 | ITK | 1.06522831 |
| 42 | MARK3 | 1.04205246 |
| 43 | MARK2 | 1.03623756 |
| 44 | PDPK1 | 1.00548885 |
| 45 | BMPR2 | 0.98058433 |
| 46 | IKBKB | 0.93203609 |
| 47 | MATK | 0.90495575 |
| 48 | STK10 | 0.87163074 |
| 49 | IRAK2 | 0.85852808 |
| 50 | SIK2 | 0.83325670 |
| 51 | MAP3K2 | 0.80904298 |
| 52 | IRAK1 | 0.80459680 |
| 53 | TAOK2 | 0.77814905 |
| 54 | PIK3CG | 0.76933431 |
| 55 | MAP3K6 | 0.75985722 |
| 56 | CDK19 | 0.75770456 |
| 57 | PRKD2 | 0.73505116 |
| 58 | PTK6 | 0.73167001 |
| 59 | MAPK7 | 0.71108941 |
| 60 | MAP3K7 | 0.69996526 |
| 61 | TRIB3 | 0.69881185 |
| 62 | PTK2B | 0.68946686 |
| 63 | FYN | 0.67967298 |
| 64 | DYRK1B | 0.67191257 |
| 65 | STK38 | 0.67116755 |
| 66 | MAPK12 | 0.66863796 |
| 67 | SGK3 | 0.62828168 |
| 68 | TGFBR2 | 0.61606791 |
| 69 | CAMKK2 | 0.57816207 |
| 70 | TESK2 | 0.57640327 |
| 71 | LRRK2 | 0.57575786 |
| 72 | MAP2K4 | 0.55418225 |
| 73 | RPS6KC1 | 0.54892127 |
| 74 | RPS6KL1 | 0.54892127 |
| 75 | PRKCQ | 0.53573410 |
| 76 | STK11 | 0.53306886 |
| 77 | CDC42BPA | 0.49371523 |
| 78 | RPS6KA6 | 0.47025119 |
| 79 | FGFR3 | 0.46865319 |
| 80 | SGK2 | 0.46187929 |
| 81 | GRK7 | 0.44995131 |
| 82 | MAP3K5 | 0.44866386 |
| 83 | MOS | 0.42577492 |
| 84 | WNK1 | 0.41468282 |
| 85 | HIPK2 | 0.39852677 |
| 86 | RET | 0.37702834 |
| 87 | KSR1 | 0.37665180 |
| 88 | RAF1 | 0.36237590 |
| 89 | NLK | 0.35953966 |
| 90 | DAPK2 | 0.35605078 |
| 91 | PIM1 | 0.35304057 |
| 92 | CAMK4 | 0.35240135 |
| 93 | CAMKK1 | 0.35138028 |
| 94 | CAMK1D | 0.32675012 |
| 95 | RPS6KA2 | 0.30767467 |
| 96 | MAP2K2 | 0.29521618 |
| 97 | MAPKAPK2 | 0.28433381 |
| 98 | SMG1 | 0.28251106 |
| 99 | MAP3K8 | 0.27068279 |
| 100 | FGFR4 | 0.26297415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.07946489 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03601265 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70027878 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.54988828 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44997029 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.39940117 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22357532 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21318901 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19038826 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.16842645 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04398764 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00694235 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93584121 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.86518028 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84310573 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82775636 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78849764 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74080202 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.69044949 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64871071 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63615736 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63354172 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63160011 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.62379955 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59091037 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58665666 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.52688996 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51958989 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47595361 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46190088 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.43968634 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34007194 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30660748 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.30367974 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27299424 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26037994 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23254854 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20466766 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18181907 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.18157730 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17464238 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17403719 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.14944710 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08357631 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03341781 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 0.99454198 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.89622219 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88542314 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88042731 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.87718715 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.86226472 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84612351 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83514026 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81034381 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80727868 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.80444196 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.78988038 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78376549 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78323914 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76621595 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75655045 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75613099 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74796556 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74695180 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74029134 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72422295 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72301490 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69208079 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68984930 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67516215 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.66645989 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65837248 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65688985 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65633142 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65141635 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64676208 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64621607 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61965869 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59403825 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59075067 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58981732 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57300648 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56039344 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54537490 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51911146 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51437812 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50635505 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50561191 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47521837 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46856775 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45587431 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45172433 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.44861937 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44564119 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43454999 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41889264 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39606739 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35682573 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35538863 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32609988 |

